ANNELATED CARBAMOYLASE-HETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE PRODUCTION THEREOF
申请人:"Chemical diversity Research Institute", Ltd.
公开号:EP1746100A1
公开(公告)日:2007-01-24
This invention relates to novel annellated carbamyl-aza-heterocyclic compounds that are potential physiologically active compounds (agonists, antagonists, and receptor modulators, enzyme inhibitors, oncolytics, antibacterial and antiparasitic agents, and so on), to a focused library comprising annellated carbamyl-aza-heterocyclic compounds, a pharmaceutical composition comprising annellated carbamyl-aza-heterocyclic compounds as the active ingredient, and to methods of producing and using the same.
The invention relates to annellated carbamyl-aza-heterocyclic compounds of general formula 1:
wherein:
W is 6-oxopiperazine, [1,4]diazepan, [1,4]thiazepan or [1,4]oxazepan compound annellated to at least one optionally substituted and optionally condensed heterocyclic compound Q;
R1, R2 and R3 are, independently of one another, a hydrogen atom, an inert substituent, an optionally substituted C1-C6 alkyl, an optionally substituted C3-C8 cycloalkyl, an optionally substituted phenyl, an optionally substituted aryl, or an optionally substituted heterocyclyl; and
Q is a pyrrole, pyrazole, imidazole, thiazole, pyrrolidine, indole, benzofuran, 4,5,6,7-tetrahydrobenzothiophene, thieno[3,2-b]pyrrole, furo[3,2-b]pyrrole, thieno[2,3-b]pyrrole, benzimidazole, pyridine, quinoline, or 1,2,3,4-tetrahydroisoquinoline cyclic compound.
本发明涉及新型的环化碳酰胺-氮杂
杂环化合物,这些化合物是潜在的生理活性化合物(激动剂、拮抗剂和受体调节剂、酶
抑制剂、抗肿瘤剂、抗菌和抗寄生虫剂等),还涉及一种包括环化碳酰胺-氮杂
杂环化合物的焦点库、一种包括环化碳酰胺-氮杂
杂环化合物作为活性成分的制药组合物,以及制备和使用这些化合物的方法。本发明涉及一般式1的环化碳酰胺-氮杂
杂环化合物:其中:W是6-氧代
哌嗪、[1,4]二氮杂环、[1,4]
硫杂环或[1,4]
噁唑杂环化合物,环化到至少一个可选取代和可选缩合的
杂环化合物Q;R1、R2和R3独立地是氢原子、惰性取代基、可选取代的C1-C6烷基、可选取代的C3-C8环烷基、可选取代的苯基、可选取代的芳基或可选取代的杂环基;Q是
吡咯、
吡唑、
咪唑、
噻唑、
吡咯烷、
吲哚、
苯并呋喃、4,5,6,7-四氢
苯并噻吩、
噻吩[3,2-b]
吡咯、呋吒[3,2-b]
吡咯、
噻吩[2,3-b]
吡咯、
苯并咪唑、
吡啶、
喹啉或1,2,3,4-
四氢异喹啉环化合物。